Astrazeneca (AZN) Receivables - Net (2009 - 2026)
Astrazeneca's Receivables - Net was $14.33 billion in Q2 2026, up 1.1% from $14.17 billion a year earlier and up 1.6% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Astrazeneca came in at $15.18 billion, up 17.0% from FY2024.
- Receivables - Net has now increased for nine consecutive years, with a five-year compound annual growth rate of 16.7% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $12.97 billion in FY2024 (+7.0%), $12.13 billion in FY2023 (+15.3%), $10.52 billion in FY2022 (+9.1%) and $9.64 billion in FY2021 (+37.3%).
- Quarterly Receivables - Net has moved between $8.26 billion (Q3 2021) and $15.18 billion (Q4 2025) over five years.
- Compared with a year earlier, Receivables - Net has increased for eight straight quarters, with growth averaging 13.2% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2021 (growth of 45.7%); the worst was Q2 2024 (a decline of 0.4%).
- Per Business Quant data, AZN's Receivables - Net in the three quarters before Q2 2026 was $14.11 billion (Q1 2026), $15.18 billion (Q4 2025) and $14.34 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.33 Bn |
| Mar 31, 2026 | 14.11 Bn |
| Dec 31, 2025 | 15.18 Bn |
| Sep 30, 2025 | 14.34 Bn |
| Jun 30, 2025 | 14.17 Bn |
| Mar 31, 2025 | 13.25 Bn |
| Dec 31, 2024 | 12.97 Bn |
| Sep 30, 2024 | 11.88 Bn |
| Jun 30, 2024 | 11.05 Bn |
| Mar 31, 2024 | 11.07 Bn |
| Dec 31, 2023 | 12.13 Bn |
| Sep 30, 2023 | 11.30 Bn |
| Jun 30, 2023 | 11.09 Bn |
| Mar 31, 2023 | 10.29 Bn |
| Dec 31, 2022 | 10.52 Bn |
| Sep 30, 2022 | 9.34 Bn |
| Jun 30, 2022 | 8.91 Bn |
| Mar 31, 2022 | 8.68 Bn |
| Dec 31, 2021 | 9.64 Bn |
| Sep 30, 2021 | 8.26 Bn |
API Access
Astrazeneca Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();